Instruction for use: Sustanon 250

Active substance:

Testosterone [mixture of esters]

ATX code

G03BA03 Testosterone

Pharmacological group

Androgens, antiandrogens

Antineoplastic hormonal agents and hormone antagonists

Nosological classification (ICD-10)

E25 Adrenogenital disorders

Macroghenytozomy in boys, Adrenogenital syndrome, Decreased function of the sex glands, Congenital dysfunction of the adrenal cortex, Apera-Halle Syndrome, Crook-Apera-Halle Syndrome

E29 Testicular dysfunction

Hypofunction of gonads in men, Androgenic dysfunction, Dysfunction of the sex glands, Dysfunction of gonads in men, Underdevelopment of the genitals in men, Primary hypogonadism in men

F52.2 Lack of genital response

Secondary impotence, Hypoxeality, Impotence, Impotence on the basis of neurasthenia, Impotence on the background of functional nervous disorders, Impotence of different origin, Violation of potency, Erection disorder, Potency disorders, Erectile Dysfunction, Disturbances of an erection of a various genesis, Inadequate erection, Weakening the potency, The weakening of sexual activity, Erection loss, Decrease in sexual potency in men, Sexual disorders in men, Sexual disorders, Weak potency, Decreased potency, Reduced potency, erectile disfunction, Erectile dysfunction, neurogenic

M81.9 Other specified osteoporosis

Osteoporosis due to androgen deficiency, Primary osteoporosis, Osteoporosis in men, Parathyroid osteoporosis, Primary osteoporosis, Post-traumatic osteoporosis, Loss of calcium in bones and teeth, Presennial osteoporosis, Systemic osteoporosis

N50 Other diseases of male genital organs

Composition

1 ampoule with 1 ml of oily solution for injection contains testosterone propionate 30 mg, testosterone phenylpropionate 60 mg, testosterone isocaproton 60 mg, testosterone decanoate 100 mg; In a contour acheive box, in a box 1 pc.

pharmachologic effect

The pharmacological action is androgenic.

Stimulates the development of male genital organs and secondary sexual characteristics, controls spermatogenesis, affects protein, nitrogen and phosphorus metabolism.

Pharmacodynamics

Androgenic effects develop rapidly and last for 3 weeks (because the solution contains four testosterone esters, differing in the rate of intake and duration of action).

Indication

Hormone replacement therapy: post-stroke syndrome, euthanism, hypopituitarism, endocrine impotence, menopausal disorders in men (including decreased libido, mental and physical activity), osteoporosis due to androgen deficiency.

Contraindications

Carcinoma of the prostate or breast (including suspected).

Side effects

Priapism, increased sexual arousal, premature puberty of boys, an increase in the size of the penis, early closure of the epiphyses of bones, oligospermia, decreased ejaculate volume, sodium and water retention.

Dosing and Administration

In / m, deep in the muscle. The dosage regimen is selected in accordance with the individual reaction; As a rule, 1 ml every 3 weeks.

Precautionary measures

When androgen-dependent adverse reactions appear, treatment should be discontinued and resumed after they disappear, prescribing reduced doses. With caution apply for dysfunction, hypertension, epilepsy, migraine (including in the anamnesis), t. A delay in sodium and water is possible.

storage Conditions

In the dark place at a temperature of 8-30 ° C.

Keep out of the reach of children.

Shelf life

5 years.

Do not use after the expiry date printed on the package.